Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Related Searches:
December 1, 2010
Wesley P. Wheeler, chief executive officer and president of Patheon has left the company.   Read More »
December 1, 2010
Novartis will cut 1,400 jobs in the U.S. as part of a restructuring effort to streamline its business and to focus on specialty medicines.  Read More »
December 1, 2010
Axcan Holdings will acquire all outstanding shares of Eurand for approximately $583 million in cash.  Read More »
December 1, 2010
Pam Tyler, a purchasing manager at DPT Laboratories, was recently recognized by the Drug, Chemical and Associated Technology Association (DCAT) for her service to the organization.   Read More »
November 30, 2010
Chris Beaver, Ph.D. has been appointed director of Immunochemistry Services at PharmaNet Development Group.  Read More »
November 30, 2010
Kenneth C. Frazier, currently president of Merck, has been appointed chief executive officer and president of the company, as well as a member of the board, effective January 1, 2011.  Read More »
November 30, 2010
RiconPharma has acquired a cGMP pharmaceutical manufacturing company in Fairfield, NJ to be called Mirror Pharmaceuticals LLC.   Read More »
November 30, 2010
Array BioPharma has achieved a $10 million clinical research milestone in its collaboration with Celgene, with the planned initiation of a Phase I dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor.  Read More »
November 29, 2010
Almac has added a dedicated late stage customization suite to its commercial facilities in Europe.  Read More »
November 29, 2010
Pfizer and Protalix BioTherapeutics have submitted a Marketing Authorization Application to the EMA for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD), for the treatment of Gaucher disease.  Read More »
November 29, 2010
Accentia Biopharmaceuticals has entered a strategic agreement with Baxter Healthcare providing Accentia the exclusive, worldwide right to purchase Baxter’s cyclophosphamide — marketed under the brand name Cytoxan — for the treatment of a  Read More »
November 29, 2010
Quintiles and London Genetics have entered a strategic alliance to offer pharmacogenetics solutions to the biopharmaceutical industry in an effort to advance personalized medicine.  Read More »
November 24, 2010
GlaxoSmithKline will transfer ownership of its penicillin manufacturing site in Bristol, TN, and rights for the Augmentin and Amoxil brands in the U.S. to Dr. Reddy’s Laboratories.  Read More »
November 24, 2010
Eli Lilly and Co. and Acrux received approval from the FDA for Axiron (testosterone) topical solution CIII for replacement therapy in men for conditions associated with a deficiency or absence of testosterone.  Read More »
November 23, 2010
Francois (Frans) L. Dubois has been named to the newly created position of senior vice president of Quality at Hospira, Inc., effective Jan. 3, 2011.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On